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With the universal hearing screening we can prevent auditory disorders in children. 
Aim: To characterize the program of neonatal auditory screening into a population of neonates. 
Materials and Methods: longitudinal cohort study. We surveyed the clinic’s database on neonatal 
auditory screening in the city of Porto Velho, Rondônia. 
Results: Among the 6,889 newborns in the database, 5,700 (82.7%) passed and 1,189 (17.3%) failed 
the first screening. Of the group which failed 900 (75.7 %) returned for retesting. Among these, 15 
(0.22 %) newborns had hearing loss confirmed. The most prevalent was neural hearing loss with 
46.7% confirmed cases; they had hyperbilirubinemia as the most prevalent risk factor. 
Conclusion: hyperbilirubinemia was the most prevalent risk factor found in the group of hearing 
impaired children. The prevalence of hearing loss was of 2 in 1,000 newborns. It is important to 
highlight the relevant association between neural hearing loss caused by hyperbilirubinemia and 
sensorineural hearing loss of unknown causes.
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INTRODUCTION
Hearing may be the main means of contact men has 
with the environment, at least as far as basic interaction 
goes, which allows for the development of language and 
the intellect. For this reason, nature provided men with 
a noteworthy system to capture, amplify, perceive, dis-
criminate and interpret sounds. It is in this order that the 
entire sound energy processing happens from the time it 
gets to the ear pinna, until it reaches the cerebral cortex ¹.
One of the main disorders which may impact lan-
guage and speech development is hearing impairment. The 
American Speech-Language-Hearing Association considers 
that hearing impairment represents 60% of communication 
disorders2.
Hearing impairment can be classified as to the time 
when it occurs. Whether the hearing loss happens before 
or during birth - called congenital hearing loss; and when 
it happens after birth it is called acquired hearing loss3. 
Hearing loss is the most frequent and prevalent disorder 
found among those routinely screened in preventive health 
care programs4.
According to the Brazilian Committee of Hearing 
Loss in Children5, the incidence of significant bilateral he-
aring loss in healthy neonates is estimated to be between 
one and three neonates for every 1,000 births and in about 
2 to 4 for every 1,000 babies coming from the Intensive 
Care Unit (ICU).
In 1994, the Joint Committee on Infant Hearing 
(JCIH)6 established the goal of universal detection of 
hearing loss in children through Universal Neonatal He-
aring Screening (UNHS), and the development of studies 
to detect them, so as to make early intervention possible.
In 1998 the Universal Neonatal Hearing Screening 
Support Group (UNHSSG) was created, under the coordi-
nation of audiologist Mônica Jubran Chapchap, with the 
goal of making UNHS operational in Brazil. Since then, 
negotiations are under way in order to create a committee 
to draw UNHS resolutions4.
The first resolution of the Brazilian Committee 
on Hearing Loss in Children (BCHLC)5 was drawn on 
11/29/1999 and one of its recommendations was to im-
plement Universal Neonatal Hearing Screening (UNHS) for 
all children from birth to three months of age.
Routine Neonatal Hearing Screening (NHS) is the 
only strategy capable of early detection of hearing changes 
which can impact the individual’s quality of life. Hearing 
changes detection process must start with neonatal hea-
ring screening, being followed by diagnosis, hearing aid 
device fitting and early interventions. The first six months 
of life are decisive concerning the future development of 
children with hearing impairment4.
The American Academy of Pediatrics recommends 
the use of electrophysiological methods in NHS programs 
such as the Brainstem Auditory Evoked Potentials (BAEP) 
and Evoked Otoacoustic Emissions (EOAE) 6-8. In order 
to do an early diagnosis, newborns at risk for hearing im-
pairment or not must undergo NHS in their first 48 hours 
of life, or before hospital discharge4,5,7.
The most employed and recommended technique 
for Neonatal Hearing Screening has been Transient Evoked 
Otoacoustic Emissions, since it uses low intensity acoustic 
stimuli, involving a broad range of frequencies and for 
being fast - taking about one minute per ear9.
BAEP aims at detecting mild to profound, conduc-
tive or sensorineural, uni or bilateral hearing losses. It 
is a non-invasive procedure, with proper specificity and 
sensitivity to examine newborns, reporting not only on 
the electrophysiological thresholds, but also the neurolo-
gic maturity as an important indicator, thus considering 
the growing number of preterm newborns found in the 
neonatal units10.
Diagnosis with early intervention can effectively 
contribute to improve the child’s development when 
followed by a proper rehabilitation program11.
In order to achieve a quality monitoring of the ne-
onatal hearing screening, it is necessary to have qualified 
professionals, control and calibration of the procedures, 
a database system, planning and evaluation of the pro-
cedures12.
Considering the lack of a neonatal auditory scre-
ening program in the city of Porto Velho, Limiar Clinic 
implemented the first NHS program in August of 2002, 
at the Dr. Ary Pinheiro Base Hospital. Limiar is a clinic 
certified and partner to the Public Health Care System 
(SUS), specialized in hearing diagnosis and rehabilitation, 
providing speech and hearing therapy for the state since 
August of 2001.
The NHS program team in Porto Velho was initially 
made up of two speech and hearing therapists and two 
secretaries, and there was no database implemented in 
order to manage the NHS data. Currently, the team counts 
on four secretaries, ten speech and hearing therapists, two 
ENT physicians, one social worker, one pediatrician, one 
neurologist and one psychologist. After many years we 
noticed the need to implement a database which would 
provide effective access to data and the follow up of those 
children who failed NHS.
The protocol used in the program has been sugges-
ted by the Universal Neonatal Hearing Screening Support 
Group (UNHSSG)4
The care for the newborn babies coming from the 
neonatal ICU and joint quarters happens before hospital 
discharge everyday of the week.
Given the aforementioned and the lack of epide-
miological data on hearing impairment during childhood 
in the city of Porto Velho, the present study aimed at 
characterizing the neonatal hearing screening program 
developed at the Clínica Limiar in Porto Velho-RO.
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MATERIALS AND METHODS
This study was approved by the Ethics in Research 
Committee of the School under protocol # 322/08.
Study design: longitudinal historical cohort.
The data used in this study was collected from the 
Hearing Evaluation and Rehabilitation Clinic - LIMIAR, 
since this institution is responsible for neonatal hearing 
screening in the city of Porto Velho, state of Rondônia - 
Brazil. The data was collected from February of 2004 to 
October of 2006. Our sample involved 6,889 registered 
patients seen in the Dr. Ary Pinheiro Base Hospital.
We used the HITRACK 3.5 database software to 
manage NHS data. From this software we can obtain the 
number of newborns (NB) screened in joint quarters and 
those coming from the neonatal ICU, the number of NB 
who passed and failed the screening, number of new-
borns referred for diagnosis, risk indicators belonging 
to the registered newborns, number of NBs who were 
diagnosed with hearing impairment, their type and level 
of impairment.
The data collected was then submitted to statistical 
analysis, for which we used the Two-Proportions Equality 
Test, the Chi-Squared and the Fisher tests. We established 
0.05 (5%) as significance level (how much error there may 
be in statistical conclusions, in other words, the statistical 
error of the analyses). All confidence intervals used throu-
ghout the study had 95% of statistical confidence.
RESULTS
In our database we have 6,889 RNs registered, 
concerning the period from February of 2004 to October 
of 2006; 5,271 RN (76.5%) from joint quarters and 1,618 
RN (23.5%) from the neonatal ICU. Of the 6,889 (100%) 
registered RNs, 5,700 (82.7%) passed the Transient Evoked 
Otoacoustic Emissions test and 1,189 (17.3%) were referred 
for retesting (Table 1).
Among the 1,189 (100%) RNs who failed screening 
with OAEs, 900 (75.7%) came for retesting and 289 NBs 
(24.3%) did not (Table 2).
Of all 6,889 registered NBs (100%), 15 (0.22%) had 
their hearing loss confirmed, 2 (0.03%) coming from joint 
quarters and 13 (0.19%) from the neonatal ICU (Table 3). 
In our sample, we had a prevalence of 0.22% of hearing 
loss confirmed. 
Of the 15 NB (100%) who had hearing loss con-
firmed, 7 (46.7%) had neural hearing loss, 2 (13.3%) had 
conductive hearing loss and 6 NB (40%) had sensorineural 
hearing loss (Table 4). According to the statistical analysis, 
the percentage of neural hearing loss can not be conside-
red different from that of the sensorineural hearing loss.
Table 5 depicts the results regarding risk indicators 
for the 15 NB with confirmed HL, where we can see that the 
most prevalent risk indicator was hyperbilirubinemia, with 
Table 1. Distribution of the registered patients: pass/failure.
Registered
Joint 
Quarters
Neonatal 
ICU
Total
N % N % N %
Passa 4294 62,3 1406 20,4 5700 82,7
Falha 977 14,2 212 3,1 1189 17,3
Total 5271 76,5 1618 23,5 6889 100
Legend N=absolute value; % = percentage; 
ICU = Intensive Care Unit;
Table 2. Distribution of those who failed.
Registered
Joint 
quarters
Neonatal 
ICU
Total
 N % N % N %
Retested 702 59,5 198 16,65 900 75,7
Not retested 275 23,1 14 1,2 289 24,3
Legend N=absolute value; % = percentage; 
ICU = Intensive Care Unit;
Table 3. Hearing Impairment Distribution.
Registered
Joint 
Quarters
Neonatal 
ICU
Total
 N % N % N %
Confirmed 2 0,03 13 0,19 15 0,22
Not confirmed 5269 76,47 1603 23,33 6874 99,8
Legend N=absolute value; % = percentage; 
UTI = Intensive Care Unit;
Table 4. Table 5 p-values
Confirmed HL Central Conductive
Conductive 0,046  
Sensorineural 0,713 0,099#
Equality Between Two Proportions Test
Legend HL = Hearing Loss; # p-values which because of being near 
the thresholds of acceptance are considered to have a tendency 
towards being significant.
five NBs (33.3%), followed by anoxia with two (13.3%), 
unknown cause with two NBs (13.3%), malformation with 
two NBs (13.3%), inheritance with one NB (67%), preterm/
low birth weight with one NB (6.7%), syndrome with one 
(6.7%) and one with congenital infection (6.7%). When 
we compare the hyperbilirubinemia risk indicator with the 
other indicators we notice that there was no statistically 
significant difference between them. Nonetheless, hyper-
bilirubinemia proved to be a statistically significant risk 
indicator (p-value<0.001) of neural hearing loss (Table 6).
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At the neonatal ICU we noticed a higher percentage 
of hearing impairment when compared to the NB coming 
from joint quarters, and such data was statistically signi-
ficant (Table 7). 
sment and Management Utah State University (NCHAM) 
an effective processing of the information is vital for the 
early detection and intervention on hearing impairment. 
Detection, diagnosis and intervention depend on the 
quick access to information, which is guaranteed by the 
HITRACK database13.
We noticed that the NHS program in Porto Velho/
RO followed the recommendations present in the literature, 
and the assessment and care for children with hearing loss 
are done by a multidisciplinary team4,5,7.
According to the Brazilian Committee on Hearing 
Loss in Children (BCHLC) 5, failure rates can vary between 
5 and 20% when the screening is carried out with EOAEs 
on the first 24 hours of life, dropping to 3% when done 
between 24 and 48 hours of life. In the present study, 
1,189 (17.3%) of the registered NB failed screening in the 
first stage of the NHS program (which happens before 
hospital discharge in the first 24 hours of life), matching 
literature data5,7.
A study carried out with 50 newborns during their 
first days of life and 80 during the second showed that on 
the second day of life there are significant improvements 
in the test and lower incidence of artifacts, concluding 
that the second day of life is a better time to perform the 
hearing screening in neonates with EOAE14.
In another study carried out in 2000 there was a 
significant improvement in the “pass” index of NHS after 
cleaning the external auditory meatus, and removing ver-
nix. They also detected a reduction in tympanic membrane 
mobility in 22.7% of the ears tested, showing a significant 
effect on the “failure” index in hearing screening15.
In the present investigation, of the 1,189 NB (100%) 
who failed the first stage, 900 (75.7%) returned for retes-
ting, showing a rate superior to those obtained in another 
study, which was of approximately 70%16. The program 
evasion index was of 289 NB (24.3%), this relevant data can 
be associated with the frequent instructions given by the 
professionals involved with children health to the parents/
guardians concerning NHS and the importance of hearing 
health for the development of language. Other authors17 
noticed that the rate of evasion reduced from 85% to 25% 
after reinforcing the instructions given by all professionals 
involved with NHS.
The incidence of significant bilateral hearing loss 
in healthy neonates is estimated to be between 1 and 3 
neonates for every 1,000 births4-6. Hearing loss is the most 
frequently found disorder in neonates, when compared 
to other disorders7-9. In our sample we had a prevalence 
of two neonates with hearing impairment confirmed for 
every 1,000 births, showing statistical rates similar to the 
ones found in the literature4-6 (Table 3).
In our study we noticed that of the 15 NB (100%) 
with confirmed hearing loss, the most prevalent type of HL 
was neural HL in seven NB (46.7%); however, according 
Table 5. Risk Indicator Distribution.
Risk Indicator N % p-value
Hyperbilirubinemia 5 33,3  
Anoxia 2 13,3 0,195
Unknown 2 13,3 0,195
Malformation 2 13,3 0,195
Inheritance 1 6,7 0,068#
Premature/low birth weight 
/hyperbilirubinemia
1 6,7 0,068#
Syndrome 1 6,7 0,068#
Congenital Infection 1 6,7 0,068#
Two Proportions Equality Test
Legend N=absolute value; % = percentage; # p-values for being near 
the acceptance thresholds tend to be significant.
Table 6. Association between Etiology and the Type of Loss
Etiology
Degree of Loss General 
Total Neural Sensorineural
N % N % N %
Anoxia 1 14,3% 1 16,7% 2 13,3%
Unknown 0 0,0% 2 33,3% 2 13,3%
Hyperbilirubinemia 5 71,4%* 0 0,0% 5 33,3%
General Total 6 60,0% 4 40,0% 10 100%
p-value = 0.034* Chi-Squared Test
Legend N=absolute value; % = percentage; ICU = Intensive Care 
Unit; *p-values = considered statistically significant considering the 
significance level used.
Table 7. Hearing loss distribution.
Hearing loss N % p-value
Joint quarters 2 0,03% 0,004*
ICU 13 0,19%
Legend N=absolute value; % = percentage; ICU = Intensive Care 
Unit; *p-values= considered statistically significant considering the 
level of significance used.
DISCUSSION
The implementation of a HITRACK 3.5 database star-
ted in 2008 and, therefore, we are just starting to process 
the data from these six years of neonatal hearing screening.
According to the National Center for Hearing Asses-
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to the statistical analysis (Table 4), it cannot be considered 
different from the sensorineural hearing loss percentage 
found in six NB (40%). We’ve noticed that this percenta-
ge represents 0.1% of the neural hearing loss and 0.09% 
of the sensorineural hearing loss when compared to the 
total number of registered NB (6,889 NB). According to 
the literature, NBs with risk indicators for HL have greater 
likelihood of having sensorineural hearing loss18.
We found that the most prevalent indicator was 
hyperbilirubinemia, accounting for 33.3% of the cases, 
representing 0.09% of all registered NB. Newborns with 
high bilirubin levels who require blood transfusion have 
a higher risk of developing sensorineural hearing loss10.
A retrospective study involving 1,032 pediatric 
patients with hearing loss reported 67 cases (6.5%) of 
severe hyperbilirubinemia in the neonatal period, 30 of 
these patients had overt neonatal hyperbilirubinemia as the 
only risk indicator for hearing loss. In 26 of the 30 cases 
(87%) the otoacoustic emissions (OAE) were not present, 
while in the four remaining cases (13%) the emissions 
were detected, despite the absence of BAEP response19.
Often times, the cause of the auditory neuropathy 
is unknown, nonetheless, the following conditions may be 
associated with pediatric hearing neuropathy: hyperbiliru-
binemia, neurodegenerative disorders, hydrocephaly, and 
other diseases20. In the present study, hyperbilirubinemia 
proved to be a statistically significant risk in neural hearing 
loss (Table 6).
Many authors report that the children with the hi-
ghest likelihood of having hearing loss upon screening are 
those with family history of congenital hearing loss, cra-
niofacial malformation, low birth weight, anoxia, syndro-
mes, ICU stay for more than 24 hours, hyperbilirubinemia 
and unknown etiology4,5,8,10. Such reports corroborate our 
findings, in which we observed the presence of hearing 
loss associated with unknown etiology (13.3%), anoxia 
(13.3%), craniofacial malformation (13.3%), inheritance 
(6.7%), preterm/low birth weight babies (6.7%) and con-
genital infection (6.7%).
In the joint quarters we identified two NBs with 
HL of unknown etiology, and such data was statistically 
significant, justifying the need for universal NHS4-8(Table 6).
In the neonatal ICU we found a higher number of 
HL (13 NB) since it is a population with risk indicators 
for hearing loss. This information is statistically significant 
when compared to the results found from the joint quar-
ters (Table 7).
CONCLUSION
The rate of newborns who passed the first screening 
stage was of 82.7% (5,700) and 17.3% (1,189) failed it. 
We noticed that among the 1,189 NBs (100%) who were 
referred for retesting, 24.3% (289) did not come.
The hearing loss prevalence seen was of two NBs 
for every 1,000 births.
Hyperbilirubinemia has a higher prevalence among 
the risk indicators found among NB with confirmed hearing 
loss. We also noticed a statistically significant correlation 
between the neural hearing loss and the bilirubinemia risk 
indicator and sensorineural hearing loss with unknown 
etiology.
The risk indicators for hearing loss in cases diag-
nosed with hearing impairment were hyperbilirubinemia, 
unknown etiology, anoxia, craniofacial malformation, 
inheritance, prematurity/low birth weight, syndrome and 
congenital infection.
Based in the present study, we stress the need for 
using BAEP in the NHS of NBs with hearing loss risk and 
to follow these children with confirmed diagnosis of HL 
up. Health care professionals involved in NHS programs 
must use a database which may, in the future here in Brazil, 
help develop a multicentric study on pediatric hearing loss.
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